Core Features and Clinical Implications of Digital Platforms for Oncology Patients: A Narrative Review of the Past Decade
Abstract
Objective:
To explore the features, benefits, and challenges of digital health platforms in oncology care based on literature published from 2015 to 2025.
Summary of Background Data:
Digital health tools, such as mobile applications, wearable devices, and electronic patient-reported outcomes (ePRO) systems, are increasingly used in oncology. These platforms aim to support symptom management, patient education, and communication between patients and providers, particularly in the context of chronic and complex cancer care. The COVID-19 pandemic further accelerated the adoption of digital health technologies, highlighting their role in maintaining continuity of care.
Methods:
This narrative review synthesized findings from peer-reviewed studies published between 2015 and 2025, focusing on the design, implementation, and clinical impact of digital platforms for cancer patients.
Results:
Digital health interventions demonstrated improvements in patient quality of life, treatment adherence, and reductions in emergency department visits. Remote monitoring and teleconsultation were particularly effective during the COVID-19 pandemic. However, persistent barriers include digital literacy gaps among older adults, concerns about data privacy and security, and a lack of robust long-term outcome data
Conclusion:
Digital platforms offer meaningful benefits in oncology care but face implementation and equity challenges. Future development should prioritize user-centered design, integration of emerging technologies (e.g., AI, blockchain, digital twins), and comprehensive policy frameworks. Large-scale studies are needed to evaluate long-term effectiveness, cost-efficiency, and equitable access.
Contributor Notes